Optimi Health Announces Investor Relations Agreement
08 mars 2022 13h49 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
16 févr. 2022 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Appoints Principal Investigator for Clinical Dosing Study
19 oct. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Joins First Psychedelic Exchange Traded Fund
13 juil. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
Optimi Health Engages U.S. Based Law Firm for Patent Support
23 juin 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 23, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a vertically integrated developer of mushroom...
OPTIMI HEALTH and NUMINUS WELLNESS to Conduct Psychedelic Lab Research and Development
02 mars 2021 09h00 HE
|
Optimi Health Corp.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) --...
Optimi Health Corp. Completes Oversubscribed $20.7 Million Initial Public Offering, and Announces Listing on the CSE
25 févr. 2021 09h00 HE
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (“Optimi” or the...
Optimi Health Corp. Receives Receipt For Final Prospectus and Conditional Approval to List on the CSE
18 févr. 2021 15h18 HE
|
Optimi Health Corp.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (“Optimi” or the “Company”),...